PUBLISHED DATE : Apr 2022 | Pages : 194
Fill out your details & get your free sample
The U.S. Remote Patient Monitoring Market Size, Growth, Share, Trends Analysis Report by:
194 Pages
60 Tables
81 Charts
1 Regions
1 Countries
44 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (2027) | USD 23 Billion |
| CAGR (2022-2027) | 12.6% |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| MARKET SEGMENTS | Component, Applications, and End-Users |
| GEOGRAPHIC ANALYSIS | United States |
The US remote patient monitoring market size is expected to surpass USD 23 billion by 2027, growing at a CAGR of 12.6% during the forecast period. The rising adoption of telemedicine, the increasing prevalence of chronic diseases, and a paradigm shift toward home healthcare drive the market’s growth. Remote patient monitoring, also known as remote physiologic monitoring, uses digital technologies to monitor and capture medical and other health data from patients and electronically transmit this data to healthcare providers for evaluation and, if necessary, recommendations and instructions. RPM can also assist in minimizing the number of hospitalizations, readmissions, and duration of stay in the hospital, all of which help enhance the quality of life while keeping the expenses in check.
The following factors are likely to contribute to the U.S. remote patient monitoring market growth during the forecast period:
According to the Arizton market research report, the U.S. remote patient monitoring market is expected to grow between 2021 and 2027 due to the increased demand for remote patient monitoring systems and devices due to the COVID-19 pandemic. The growth of the market can be ascribed to several factors, including technological improvements, a greater focus on public health, more consumer awareness of the benefits of remote patient monitoring devices, and lower prices. The telemedicine approach incorporating remote patient monitoring is growing exponentially. The manufacturers are making less invasive and more minor solutions and planning to collaborate and partner with new players to expand their market share. Moreover, several traditional medical device manufacturers are gradually expanding their product portfolios and focusing on launching remote patient monitoring devices integrated with advanced technologies, such as the Internet of Things.
The presence of substantial competitors and their growth strategies are the main factors driving the U.S. remote patient monitoring market growth. The US market is driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. Growing recognition of RPM as a tool to proactively monitor and improve patient engagement is expected to boost the market in the United States. The government's involvement in introducing telehealth to rural areas and the existence of significant corporations in the United States contribute to the market growth.
Remote Patient Monitoring Systems Working Structure
Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions to the patients are provided. Remote patient monitoring reduces the number of readmissions in the medical requirement, hospitalizations, and lengths of stay in the hospital, which lead to improved quality of life and contain costs.
Partnership and Product Launches to Increase U.S. Remote Patient Monitoring Market Share
Increasing Number Of Technology Innovation In Wearable Medical Devices
The wearable health devices are increasingly assisting people in better monitoring their health condition, both on a personal level for self-health tracking and a medical level, by sending more data to professionals, potentially allowing for earlier diagnosis and treatment assistance. The shrinking of electronic devices enables the development of more dependable and flexible wearables, contributing to the health monitoring method. Wearables, like implanted devices, have the advantage of being able to be designed as smart gadgets that can offer digital health data and assist telemedicine. Thanks to technological capabilities in wearables, patients and clinicians can more readily monitor vital signs and physiological and biochemical indicators, such as glucose levels and physical activity. Wearable drug delivery systems also provide a dependable method of pharmacological therapy without needing trained persons to administer it. These capabilities improve the accuracy of patient tests and treatments, resulting in a better patient experience while also lowering healthcare expenditures. These considerations contribute to the growing popularity of remote patient monitoring systems.
The Increased Use Of Mobile Technologies And Smart Devices For Remote Patient Monitoring
Remote monitoring has emerged as a novel and significant telemedicine paradigm over the last decade. COVID-19 necessitates scalable, near-real-time interactions with populations. Remote monitoring, particularly asynchronous communication, has specific operating and design qualities that are ideally suited for COVID-19. Monitoring can collect epidemic data and acquire real-time clinical input in particular. Remote monitoring is becoming a crucial tool for payers, clinicians, and public health officials as telemedicine evolve. COVID-19 is bringing telemedicine to the forefront of national attention, which has been long needed but comes at a difficult time. The need for population-level screening has arisen due to COVID-19, and telemedicine is well-positioned to facilitate this. Telemedicine is a key component in the ever-changing environment of a growing epidemic, providing care beyond the traditional face-to-face format. These factors have aided the market expansion of the remote patient monitoring industry.
The US remote patient monitoring market is bifurcated by component, application, end-user, and region. Based on components, the market is again divided into devices, software, and services. The Devices and Software segment accounts for the largest share of the Services segment in the U.S. remote patient monitoring market. The increasing adoption of wearable medical devices, technological advancements in IoT, and the rise in the adoption of home healthcare systems are expected to boost the adoption of the device & software segment in the remote patient monitoring market.
Ways Healthcare IoT & Remote Patient Monitoring Are Transforming Care Delivery
The cardiology remote patient monitoring systems accounted for the maximum share in the U.S. remote patient monitoring market. According to CDC, 659,000 people in the US die from heart disorders every year, which is 1 in every 4 deaths due to heart diseases. Statistics from the Centers for Disease Control and Prevention (CDC) demonstrate RPM is becoming more popular in cardiology. Nearly one out of every two persons in the US has hypertension, and most of these adults do not have their hypertension under control. According to estimates, 6.1 million people in the US have atrial fibrillation (AF), which is expected to climb as the population ages. Finally, according to CDC estimates, more than 42% of the American population were obese in 2017–2018, compared to around 31% in 1999–2000. Thus, the country's high incidence of heart diseases is expected to drive the cardiology segment during the forecast period.
The hospitals and specialty clinics accounted for the largest share in the U.S. remote patient monitoring market, and the Homecare setting is anticipated to be the fastest-growing end-user. With the increased demand for hospital beds and the challenge of delivering care with staff shortages, some health care centers prefer remote patient monitoring solutions. Moreover, technological advancements have made it viable to monitor patients remotely while at home or in skilled nursing facilities. Wireless monitors, cloud-based platforms, and telemedicine have allowed health systems to seamlessly use at-home continuous pulse oximeters to monitor patients and help avoid hospitalizations; these factors are expected to boost the homecare setting segment's market growth significantly.
The US remote patient monitoring market is somewhat fragmented, with many top companies in the US market and several small players in regional markets. Leading companies dominate the global RPM market. The major competitors in the industry are focusing on reducing the size of remote patient monitoring devices. These companies also attempt to increase their market share by launching new goods and collaborating with other industry participants. As a result, these factors are expected to increase the remote patient monitoring market size.
Medtronic, Philips Healthcare, and ResMed are among the leading companies in the U.S. remote patient monitoring market for Devices and Software. Withings, MedM, iHealthUnifiedcare, and Qardio are among the top companies in the U.S. remote patient monitoring market services.
100Plus, A&D Medical, Abbott, Altumview Systems, Biotronik, Boston Scientific, Bardy Diagnostics, Cardiomo, Cardiologs, Dragerwerk AG, F. Hoffmann-La Roche Ltd, Fluxion Biosciences, GE Healthcare, GrandCare Systems, Masimo Corporation, Nihon Kohden, Omron Healthcare, OSPLabs, Qualcomm Technologies, Senseonics, VitalConnect, and others are among the leading players in the U.S. remote patient monitoring market.
Frequently Asked Questions
WHAT WILL BE THE SIZE OF THE US REMOTE PATIENT MONITORING MARKET BY 2027?
The US Remote Patient Monitoring Market is expected to reach USD 23 billion by 2027.
WHAT ARE THE FACTORS CONTRIBUTING TO THE U.S. REMOTE PATIENT MONITORING MARKET GROWTH?
An increasing number of technology innovations in wearable medical devices, the increased use of mobile technologies, and smart devices for remote patient monitoring are some of the factors contributing to the market growth.
WHO ARE THE KEY PLAYERS IN THE MARKET?
Medtronic, Philips Healthcare, and ResMed are some of the key players in the market.
WHICH APPLICATION HOLDS THE HIGHEST SHARE IN THE U.S. REMOTE PATIENT MONITORING MARKET?
The cardiology remote patient monitoring segment accounted for the highest share.
WHAT ARE THE LATEST TRENDS IN THE REMOTE PATIENT MONITORING MARKET IN THE US?
Telemedicine, the Increasing role of the Internet of Things (IoT) are some of the latest trends in the market.
The US remote patient monitoring market size was valued at USD 11.31 billion in 2021 and is expected to reach USD 23.07 billion by 2027, growing at a CAGR of 12.63%.
The report considers the present scenario of the U.S. remote patient monitoring market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
Base Year: 2021
Forecast Year: 2022-2027
Key Vendors
Other Prominent Vendors
Segmentation by Component
Segmentation by Devices
Segmentation by Application
Segmentation by End-User
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY, & REMOTE MONITORING
8.2 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING
8.3 INCREASING ROLE OF INTERNET OF THINGS (IOT) IN REMOTE MONITORING & HEALTHCARE
9 MARKET GROWTH ENABLERS
9.1 INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES
9.2 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING
9.3 AGING POPULATION VULNERABLE TO CHRONIC DISEASES
9.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT
10 MARKET GROWTH RESTRAINTS
10.1 REGULATORY VARIATIONS ACROSS COUNTRY
10.2 LACK OF DATA ACCURACY
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 MARKET SHARE BY COMPONENT
11.2.2 MARKET SHARE BY DEVICES & SOFTWARE
11.2.3 MARKET SHARE BY APPLICATION
11.2.4 MARKET SHARE BY END-USER
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 COMPONENT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
13 DEVICES & SOFTWARE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.2.1 MARKET SIZE & FORECAST
13.3 CARDIAC MONITORING DEVICES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 ELECTROCARDIOGRAPHS (ECGS): MARKET OVERVIEW
13.3.4 MARKET SIZE & FORECAST
13.3.5 CARDIAC MONITORS: MARKET OVERVIEW
13.3.6 MARKET SIZE & FORECAST
13.3.7 BLOOD PRESSURE MONITORS: MARKET OVERVIEW
13.3.8 MARKET SIZE & FORECAST
13.3.9 OTHERS: MARKET OVERVIEW
13.3.10 MARKET SIZE & FORECAST
13.4 RESPIRATORY MONITORING DEVICES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 APNEA MONITORS: MARKET OVERVIEW
13.4.4 MARKET SIZE & FORECAST
13.4.5 PULSE OXIMETERS: MARKET OVERVIEW
13.4.6 MARKET SIZE & FORECAST
13.4.7 OTHER RESPIRATORY MONITORING DEVICES: MARKET OVERVIEW
13.4.8 MARKET SIZE & FORECAST
13.5 BLOOD GLUCOSE MONITORS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.6 FETAL & NEONATAL MONITORING DEVICES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.7 OTHER RPM DEVICES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
14 SERVICES
14.1 MARKET OVERVIEW
14.2 MARKET SIZE & FORECAST
15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CARDIOLOGY
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 PULMONOLOGY
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.5 ENDOCRINOLOGY
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 OTHERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS & SPECIALTY CLINICS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 HOMECARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 AMBULATORY SURGICAL CENTERS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 LONG-TERM & ACUTE CARE CENTERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 OTHERS
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
17 COMPETITIVE LANDSCAPE
17.1 COMPETITION OVERVIEW BY DEVICES & SOFTWARE
17.1.1 MEDTRONIC
17.1.2 PHILIPS HEALTHCARE
17.1.3 RESMED
17.2 COMPETITION OVERVIEW BY SERVICES
17.2.1 MEDM
17.2.2 IHEALTHUNIFIEDCARE
17.2.3 QARDIO
18 KEY VENDORS
18.1 MEDTRONIC
18.1.1 BUSINESS OVERVIEW
18.1.2 PRODUCT OFFERING
18.2 PHILIPS HEALTHCARE
18.2.1 BUSINESS OVERVIEW
18.2.2 PRODUCT OFFERING
18.3 RESMED
18.3.1 BUSINESS OVERVIEW
18.3.2 PRODUCT OFFERING
19 OTHER PROMINENT VENDORS
19.1 100-PLUS
19.1.1 BUSINESS OVERVIEW
19.1.2 PRODUCT OFFERINGS
19.2 A&D COMPANY
19.2.1 BUSINESS OVERVIEW
19.2.2 PRODUCT OFFERINGS
19.3 ABBOTT
19.3.1 BUSINESS OVERVIEW
19.3.2 PRODUCT OFFERINGS
19.4 ALTUMVIEW SYSTEMS
19.4.1 BUSINESS OVERVIEW
19.4.2 PRODUCT OFFERINGS
19.5 BIOTRONIK
19.5.1 BUSINESS OVERVIEW
19.5.2 PRODUCT OFFERING
19.6 BOSTON SCIENTIFIC
19.6.1 BUSINESS OVERVIEW
19.6.2 PRODUCT OFFERINGS
19.7 BARDY DIAGNOSTICS
19.7.1 BUSINESS OVERVIEW
19.7.2 PRODUCT OFFERINGS
19.8 CARDIOMO CARE
19.8.1 BUSINESS OVERVIEW
19.8.2 PRODUCT OFFERINGS
19.9 CARDIOLOGS
19.9.1 BUSINESS OVERVIEW
19.9.2 PRODUCT OFFERINGS
19.10 DRAGERWERK AG
19.10.1 BUSINESS OVERVIEW
19.10.2 PRODUCT OFFERINGS
19.11 F. HOFFMANN-LA ROCHE
19.11.1 BUSINESS OVERVIEW
19.11.2 PRODUCT OFFERINGS
19.12 GE HEALTHCARE
19.12.1 BUSINESS OVERVIEW
19.12.2 PRODUCT OFFERINGS
19.13 GRANDCARE SYSTEMS
19.13.1 BUSINESS OVERVIEW
19.13.2 PRODUCT OFFERINGS
19.14 HONEYWELL INTERNATIONAL
19.14.1 BUSINESS OVERVIEW
19.14.2 PRODUCT OFFERINGS
19.15 IHEALTHUNIFIEDCARE
19.15.1 BUSINESS OVERVIEW
19.15.2 PRODUCT OFFERINGS
19.16 QARDIO
19.16.1 BUSINESS OVERVIEW
19.16.2 PRODUCT OFFERING
19.17 MEDM
19.17.1 BUSINESS OVERVIEW
19.17.2 PRODUCT OFFERING
19.18 MASIMO CORPORATION
19.18.1 BUSINESS OVERVIEW
19.18.2 PRODUCT OFFERINGS
19.19 MEDOPAD
19.19.1 BUSINESS OVERVIEW
19.19.2 PRODUCT OFFERINGS
19.20 NIHON KOHDEN
19.20.1 BUSINESS OVERVIEW
19.20.2 PRODUCT OFFERINGS
19.21 OMRON HEALTHCARE
19.21.1 BUSINESS OVERVIEW
19.21.2 PRODUCT OFFERINGS
19.22 OSPLABS
19.22.1 BUSINESS OVERVIEW
19.22.2 PRODUCT OFFERINGS
19.23 RESIDEO TECHNOLOGIES
19.23.1 BUSINESS OVERVIEW
19.23.2 .PRODUCT OFFERING
19.24 SMITHS MEDICAL
19.24.1 BUSINESS OVERVIEW
19.24.2 .PRODUCT OFFERINGS
19.25 SPACELABS HEALTHCARE
19.25.1 BUSINESS OVERVIEW
19.25.2 PRODUCT OFFERINGS
19.26 SENSEONICS
19.26.1 BUSINESS OVERVIEW
19.26.2 PRODUCT OFFERINGS
19.27 TELEMEDCARE
19.27.1 BUSINESS OVERVIEW
19.27.2 PRODUCT OFFERINGS
19.28 VITALCONNECT
19.28.1 PRODUCT OFFERINGS
19.29 VITLS
19.29.1 BUSINESS OVERVIEW
19.29.2 PRODUCT OFFERINGS
19.30 MODICARE
19.30.1 BUSINESS OVERVIEW
19.30.2 PRODUCT OFFERINGS
19.31 HILLROM
19.31.1 BUSINESS OVERVIEW
19.31.2 PRODUCT OFFERINGS
19.32 VIVIFY HEALTH
19.32.1 BUSINESS OVERVIEW
19.32.2 PRODUCT OFFERING
19.33 ACL DIGITAL
19.33.1 BUSINESS OVERVIEW
19.33.2 PRODUCT OFFERINGS
19.34 DEXCOM
19.34.1 BUSINESS OVERVIEW
19.34.2 PRODUCT OFFERING
19.35 IRHYTHM TECHNOLOGIES
19.35.1 BUSINESS OVERVIEW
19.35.2 PRODUCT OFFERING
19.36 VIVALINK
19.36.1 BUSINESS OVERVIEW
19.36.2 PRODUCT OFFERING
19.37 BIOBEAT
19.37.1 PRODUCT OFFERINGS
19.38 CAREVALIDATE
19.38.1 BUSINESS OVERVIEW
19.38.2 PRODUCT OFFERINGS
19.39 BIOFOURMIS
19.39.1 BUSINESS OVERVIEW
19.39.2 PRODUCT OFFERING
19.40 CAREMINDR
19.40.1 BUSINESS OVERVIEW
19.40.2 PRODUCT OFFERING
19.41 DATOS HEALTH
19.41.1 BUSINESS OVERVIEW
19.41.2 PRODUCT OFFERINGS
20 REPORT SUMMARY
20.1 KEY TAKEAWAYS
20.2 STRATEGIC RECOMMENDATIONS
21 QUANTITATIVE SUMMARY
21.1 MARKET BY COMPONENTS
21.1.1 MARKET BY DEVICES & SOFTWARE
21.1.2 MARKET BY CARDIAC MONITORING DEVICES
21.1.3 MARKET BY RESPIRATORY MONITORING DEVICES
21.2 MARKET BY APPLICATION
21.3 MARKET BY END USER
22 APPENDIX
22.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF US REMOTE PATIENT MONITORING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY & REMOTE MONITORING
EXHIBIT 4 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES FOR THE REMOTE MONITORING
EXHIBIT 5 IMPACT OF INCREASING ROLE OF INTERNET OF THINGS (IOT) FOR REMOTE MONITORING & HEALTHCARE
EXHIBIT 6 WAYS HEALTHCARE IOT & REMOTE PATIENT MONITORING ARE TRANSFORMING CARE DELIVERY
EXHIBIT 7 IMPACT OF INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES
EXHIBIT 8 IMPACT OF GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING
EXHIBIT 9 IMPACT OF AGING POPULATION VULNERABLE TO CHRONIC DISEASES
EXHIBIT 10 IMPACT OF GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT
EXHIBIT 11 IMPACT OF REGULATORY VARIATIONS ACROSS COUNTRY
EXHIBIT 12 IMPACT OF LACK OF DATA ACCURACY
EXHIBIT 13 US REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 14 US REMOTE PATIENT MONITORING MARKET BY COMPONENT
EXHIBIT 15 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE
EXHIBIT 16 US REMOTE PATIENT MONITORING MARKET BY APPLICATION
EXHIBIT 17 US REMOTE PATIENT MONITORING MARKET BY END-USER
EXHIBIT 18 FIVE FORCES ANALYSIS 2021
EXHIBIT 19 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027
EXHIBIT 20 INCREMENTAL GROWTH BY DEVICES & SOFTWARE 2021 & 2027
EXHIBIT 21 US REMOTE PATIENT MONITORING MARKET BY PRODUCT
EXHIBIT 22 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: INCREMENTAL GROWTH
EXHIBIT 23 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: ABSOLUTE GROWTH
EXHIBIT 24 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021–2027 ($ BILLION)
EXHIBIT 25 US REMOTE CARDIAC MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 26 US REMOTE CARDIAC MONITORING DEVICES MARKET 2021–2027 ($ BILLION)
EXHIBIT 27 US ECG REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 US ECG REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 29 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS 2021–2027 ($ BILLION)
EXHIBIT 31 US REMOTE PATIENT MONITORING MARKET BY BLOOD PRESSURE MONITORS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 US REMOTE PATIENT MONITORING MARKET BY BLOOD PRESSURE MONITORS 2021–2027 ($ BILLION)
EXHIBIT 33 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 35 US REMOTE RESPIRATORY MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 36 US REMOTE RESPIRATORY MONITORING DEVICES MARKET 2021–2027 ($ BILLION)
EXHIBIT 37 US REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 US REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS 2021–2027 ($ BILLION)
EXHIBIT 39 US REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 US REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS 2021–2027 ($ BILLION)
EXHIBIT 41 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 43 US REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 US REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS 2021–2027 ($ BILLION)
EXHIBIT 45 US REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 US REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET 2021–2027 ($ BILLION)
EXHIBIT 47 US OTHER RPM DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 US OTHER RPM DEVICES MARKET 2021–2027 ($ BILLION)
EXHIBIT 49 US REMOTE PATIENT MONITORING MARKET BY SERVICES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 US REMOTE PATIENT MONITORING MARKET BY SERVICES 2021–2027 ($ BILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 52 US REMOTE PATIENT MONITORING MARKET BY APPLICATION
EXHIBIT 53 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 54 US REMOTE CARDIOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 US REMOTE CARDIOLOGY PATIENT MONITORING 2021–2027 ($ BILLION)
EXHIBIT 56 US REMOTE PULMONOLOGY PATIENT MONITORING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 US REMOTE PULMONOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 58 US REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 US REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)
EXHIBIT 60 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 62 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 63 US REMOTE PATIENT MONITORING MARKET BY END-USER
EXHIBIT 64 US REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 65 US REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 US REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS 2021–2027 ($ BILLION)
EXHIBIT 67 US REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 US REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS 2021–2027 ($ BILLION)
EXHIBIT 69 US REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 70 US REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS 2021–2027 ($ BILLION)
EXHIBIT 71 US REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 72 US REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS 2021–2027 ($ BILLION)
EXHIBIT 73 US REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 74 US REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS 2021–2027 ($ BILLION)
EXHIBIT 75 MEDTRONIC REVENUE 2018-2021 ($ BILLION)
EXHIBIT 76 MEDTRONIC SEGMENT 2021 (%)
EXHIBIT 77 PHILIPS HEALTHCARE SEGMENT 2021 (%)
EXHIBIT 78 PHILIPS HEALTHCARE REVENUE 2018-2021 ($ BILLION)
EXHIBIT 79 PHILIPS HEALTHCARE REGIONAL REVENUE 2021 (%)
EXHIBIT 80 RESMED REVENUE BY SEGMENT 2021 (%)
EXHIBIT 81 RESMED REVENUE 2018-2021 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 4 COVIDIEN PLC.: MAJOR PRODUCT OFFERINGS
TABLE 5 PHILIPS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 6 RESMED: MAJOR PRODUCT OFFERINGS
TABLE 7 100-PLUS: MAJOR PRODUCT OFFERINGS
TABLE 8 A&D COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 9 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 10 ALTUMVIEW SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 11 BIOTRONIK: MAJOR PRODUCT OFFERINGS
TABLE 12 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 13 BARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 14 CARDIOMO CARE: MAJOR PRODUCT OFFERINGS
TABLE 15 CARDIOLOGS: MAJOR PRODUCT OFFERINGS
TABLE 16 DRAGERWERK AG: MAJOR PRODUCT OFFERINGS
TABLE 17 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS
TABLE 18 ROCHE DIABETES CARE. MAJOR PRODUCT OFFERINGS
TABLE 19 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 20 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 21 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 22 IHEALTHUNIFIEDCARE: MAJOR PRODUCT OFFERINGS
TABLE 23 QARDIO: MAJOR PRODUCT OFFERINGS
TABLE 24 MEDM: MAJOR PRODUCT OFFERINGS
TABLE 25 MASIMO CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 26 MEDOPAD.: MAJOR PRODUCT OFFERINGS
TABLE 27 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS
TABLE 28 OMRON HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 29 OSPLABS: MAJOR PRODUCT OFFERINGS
TABLE 30 RESIDEO TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 31 SMITHS MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 32 SPACELABS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 33 SENSEONICS: MAJOR PRODUCT OFFERINGS
TABLE 34 TELEMEDCARE: MAJOR PRODUCT OFFERINGS
TABLE 35 VITALCONNECT: MAJOR PRODUCT OFFERINGS
TABLE 36 VITLS: MAJOR PRODUCT OFFERINGS
TABLE 37 MODICARE: MAJOR PRODUCT OFFERINGS
TABLE 38 WELCH ALLYN: MAJOR PRODUCT OFFERINGS
TABLE 39 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 40 ACL DIGITAL: MAJOR PRODUCT OFFERINGS
TABLE 41 DEXCOM: MAJOR PRODUCT OFFERINGS
TABLE 42 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 43 VIVALINK: MAJOR PRODUCT OFFERINGS
TABLE 44 BIOBEAT: MAJOR PRODUCT OFFERINGS
TABLE 45 CAREVALIDATE: MAJOR PRODUCT OFFERINGS
TABLE 46 BIOFOURMIS: MAJOR PRODUCT OFFERINGS
TABLE 47 CAREMINDR: MAJOR PRODUCT OFFERINGS
TABLE 48 DATOS HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 49 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)
TABLE 50 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 (%)
TABLE 51 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)
TABLE 52 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 (%)
TABLE 53 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 54 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 (%)
TABLE 55 US REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)
TABLE 56 US REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 (%)
TABLE 57 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 58 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 (%)
TABLE 59 US REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)
TABLE 60 US REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
